Literature DB >> 2895363

Predicting insulin-dependent diabetes.

A C Tarn1, J M Thomas, B M Dean, D Ingram, G Schwarz, G F Bottazzo, E A Gale.   

Abstract

719 first-degree relatives of diabetic children were followed up to assess the value of HLA haplotype sharing and of islet-cell antibodies (ICA) for prediction of insulin-dependent diabetes (IDDM). Within a maximum of 8 years' follow-up (3384 patient-years of observation) 16 unaffected relatives (5 parents and 11 siblings) became insulin dependent. The cumulative risk of becoming insulin dependent by age 25 was 16% for siblings sharing two HLA haplotypes with the proband, 9% for those sharing one haplotype, and zero for those sharing none. 13 of 24 (54%) subjects positive for complement-fixing ICA on three or more occasions became insulin dependent, as against 1 of 30 (3%) with noncomplement-fixing ICA alone and 2 of 665 (0.3%) ICA-negative subjects; by life-table analysis the risks after 8 years of known ICA status are 76%, 3%, and 0.6%, respectively. In terms of total time at risk ICA-positive family members had a relative risk of 75.2 compared with ICA-negative individuals. With positivity for complement-fixing ICA the relative risk was 188.5.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2895363     DOI: 10.1016/s0140-6736(88)91601-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  76 in total

Review 1.  Latent autoimmune diabetes in adults (LADA).

Authors:  Ramachandra G Naik; Jerry P Palmer
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

Review 2.  The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.

Authors:  C Boitard
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

3.  Assessment of precision, concordance, specificity, and sensitivity of islet cell antibody measurement in 41 assays.

Authors:  E Bonifacio; C Boitard; H Gleichmann; M A Shattock; J L Molenaar; G F Bottazzo
Journal:  Diabetologia       Date:  1990-12       Impact factor: 10.122

4.  Immunotherapy in pre-type 1 diabetes mellitus.

Authors:  J F Bach; J Dupré; G S Eisenbarth; L C Harrison; N K Maclaren; J Nerup; P Pozzilli
Journal:  Diabetologia       Date:  1990-12       Impact factor: 10.122

Review 5.  Management of diabetes mellitus.

Authors:  D I Johnston
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

6.  Characterization of human organ donors testing positive for type 1 diabetes-associated autoantibodies.

Authors:  A Wiberg; A Granstam; S Ingvast; T Härkönen; M Knip; O Korsgren; O Skog
Journal:  Clin Exp Immunol       Date:  2015-10-06       Impact factor: 4.330

7.  No association between islet cell antibodies and Coxsackie B, mumps, rubella and cytomegalovirus antibodies in non-diabetic individuals aged 7-19 years.

Authors:  W A Scherbaum; W Hampl; P Muir; M Glück; J Seissler; H Egle; H Hauner; B O Boehm; E Heinze; J E Banatvala
Journal:  Diabetologia       Date:  1991-11       Impact factor: 10.122

Review 8.  Immunological aspects on IDDM in children.

Authors:  J Ludvigsson
Journal:  Indian J Pediatr       Date:  1989 Nov-Dec       Impact factor: 1.967

9.  Islet-cell antibodies as predictors of the later development of type 1 (insulin-dependent) diabetes. A study in identical twins.

Authors:  C Johnston; B A Millward; P Hoskins; R D Leslie; G F Bottazzo; D A Pyke
Journal:  Diabetologia       Date:  1989-06       Impact factor: 10.122

10.  The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice.

Authors:  A Signore; P Pozzilli; E A Gale; D Andreani; P C Beverley
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.